You just read:

Phase 2 Part A Open Label Extension Trial of Palovarotene for Treatment of Patients with Fibrodysplasia Ossificans Progressiva Continues Positive Trends

News provided by

Clementia Pharmaceuticals Inc.

Mar 28, 2017, 07:30 ET